Boothbay Fund Management’s Passage Bio PASG Stock Holding History

Boothbay Fund Management’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$139K	Buy	28,439 +9,568	+51%	+$59.9K	﹤0.01%	1999
2026 Q1	$148K	Buy	+18,871	New	+$195K	﹤0.01%	1827
2022 Q3	–	Sell	-752	Closed	-$35K	–	2510
2022 Q2	$35K	Buy	+752	New	+$35.1K	﹤0.01%	2121
2021 Q3	–	Sell	-769	Closed	-$204K	–	2109
2021 Q2	$204K	Hold	769	–	–	0.01%	1515
2021 Q1	$269K	Buy	769 +54	+8%	+$23.1K	0.01%	1241
2020 Q4	$365K	Buy	+715	New	+$286K	0.01%	871

Other funds holding PASG

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

YCM

Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Verdad Advisers Boston, Massachusetts $104M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boothbay Fund Management's PASG Position: Q2 2026 in Review

Boothbay Fund Management increased its Passage Bio (PASG) stake by 51% in Q2 2026, buying an estimated $59.9K and bringing the position to 28,439 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #1999.

Boothbay Fund Management first reported a position in PASG in Q4 2020 and has held it in 6 quarters since. The position peaked at $365K in Q4 2020. 29 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

Boothbay Fund Management held 28,439 shares of Passage Bio worth $139K as of Q2 2026.
Boothbay Fund Management bought 9,568 Passage Bio shares in Q2 2026, an estimated $59.9K.
Passage Bio made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1999 holding.
Boothbay Fund Management first reported a position in Passage Bio in Q4 2020 and has held it in 6 quarters since.
Boothbay Fund Management's Passage Bio position peaked at $365K in Q4 2020.
29 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.